2Vitale M, Rezzani R, Rodella Let al. HLA class I antigen and transporter associated with antigen processing (TAP1 and TAV2) down-regulation in high-grade primary breast carcinoma lesions [ J]. Cancer Res, 1998; 58 (4) :737-742.
3Chaudhuri S, Cariappa A, Tang M et al. Genetic susceptibility to breast cancer: HLA DQB * 03032 and HLA DRBI * 11 may represent protective alleles[J]. Proc Natl Aead Sci USA,2000; 97(21 ) : 11451-11454.
4de Jong M M, Nohe I M, de Vries E Get al. The HLA class Ⅲ subregion is responsible for an increased breast cancer risk [J]. Human Mol Genet, 2003 ; 12(18) : 2311-2319.
5Sommer S and Fuqua S A. Estrogen receptor and breast cancer [J]. Semin Cancer Biol, 2001 ; 11 (5) : 339-352.
6Gourley C, Thornton C, Massie C et al. Is there a relationship between HLA type and prognostic factors in breast cancer? [J]. Anticancer Res, 2003 ; 23 ( 1 B) : 633-638.
7Gun FD, Ozturk O G, Polat A et al. HLA class-Ⅱ allele frequencies in Turkish breast cancer patients [J]. Med Oncol, 2011; doi: 10. 1007/ s12032-011-9873-4.
8Jemal A, Bray F, Center M Met al. Global cancer statistics[ J ]. CA Cancer J Clin,2011 ;61 (2) :69-90.
9Petrone A, Bugawan T L, Mesturino C Aet al. The distribution of HLA class Ⅱ susceptible/protective haplotypes could partially explain the low incidence of type 1 diabetes in continental Italy (Lazio region) [J]. Tissue Antigens, 2001 ; 58 (6) : 385-394.
10Shiina T, Inoko H, Kulski J K. An update of the HLA genomie region, locus information and disease associations: 2004[J]. Tissue Antigens, 2004 ; 64 (6) :631-649.
